Research
Journey to Human Trials
Each and every day, the promise of finding a better way to treat cancer fuels the focus and tenacity of the Kanzius RF Laboratory team.
Clinical trials conducted by Dr. Stephen Curley at The University of Texas MD Anderson Cancer Center in Houston and Dr. David Geller at The University of Pittsburgh Medical Center in Pittsburgh have yielded promising progress over the past four years. The Kanzius device is working! To download copies of published industry manuscripts, click here.
While initial clinical trials to validate effectiveness, consistency, and safety continue, work is also under way on schematics for a “human-sized” device. All indications lead us to believe that we will begin testing on this larger device by the end of this year. Once in operation, the research teams will need to demonstrate at least two years of successful clinical trials to seek FDA approval to begin the Phase I Human Trials.
Moving forward with cautious optimism, the Kanzius RF Laboratory team indicates that a best-case scenario could result in human trials within the next three years.
As with much medical research, funding is critical to ensuring the necessary staff and resources. Ongoing support and generosity are essential to our progress. Please donate now or contact the Kanzius Cancer Research Foundation to learn more.
Research
Donate
Every day and every dollar brings the Kanzius Non-invasive Radio Wave Cancer Treatment research closer to a cure for cancer!
